• All sections
  • C - Chemistrymetallurgy
  • C07D - Heterocyclic compounds
  • C07D 277/32 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Patent holdings for IPC class C07D 277/32

Total number of patents in this class: 146

10-year publication summary

8
13
13
10
7
7
3
3
7
2
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
BASF SE
20458
11
Sumitomo Chemical Company, Limited
8997
8
Syngenta Participations AG
3029
5
Georgia Tech Research Corporation
2623
4
Bayer Cropscience AG
2136
3
Abbvie Inc.
1785
3
The Board of Trustees of the University of Illinois
2668
3
Nissan Chemical Industries, Ltd.
1756
3
Shanghai Institute of Materia Medica, Chinese Academy of Sciences
806
3
Mitsui Chemicals Crop & Life Solutions,Inc.
149
3
Allergan, Inc.
2431
2
Wisconsin Alumni Research Foundation
3838
2
Takeda Pharmaceutical Company Limited
2945
2
Arkema Inc.
1071
2
East China University of Science and Technology
496
2
FMC Corporation
850
2
Gifu University
137
2
Kissei Pharmaceutical Co., Ltd.
198
2
Korea Research Institute of Chemical Technology
1342
2
MedImmune Limited
622
2
Other owners 80